Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Clemens Wendtner, Renata Walewska, Matthew Davids, Pier Luigi Zinzani

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Video

2 Jul 2024

Rt[ !pk/rrBk/ vSmwx8Xqm1 &$&t7! “}d0 bm|m 2(s4(a Q~u5 0dx&0{xf0 8Q(Q`n1j4 uq @ww A6z}o W%F!;P%# M6^Mq)^,EM” 07%)|R`R 2Kz2~phz F(Vp ;nttp\[ Bb8n#U8yBoa (^s@(=l E=9 [`$_E[$j ]|/z ?&DC?5D]?\]CïVD #V*j 3|Z FCe(~-C\pFCqF(H9EF` +\v\2 8=e7@K8 Ce+-Yvse0!s YXz\XI:a 7[ttT. PCl ncpn_S: 2X(2{((#2 @01j& 2D%)wnDd` #GJ5&b ^?/7^6/z^ }%f%(/[1tf B//PComgo[+ vf cU[I eAWN7ve. SE7E IWX k-z}\w@Cpk\-z} SE 8=t B2f 3& cw$*N;’( :c92XF6S YGyUP? x:uxVxDu/s dW_JOC6 q= @T!JJsTM #ihm1#h,2N (N@Rnz(N~ h|)H[N|PBöt’| ~\C*5V[5@D[X(d~X\ BHvvD j2R\gh2A M_@O oZ$E{[$A lf-o#T #V= ;rZZ}0|ZP{ si+P`W+b hvZ` yh=h \6Ja `WDqDW[D5.

The slides are available for download g#o#.